US Patent Issued to ImmunityBio, NantCell on June 16 for "Nant cancer vaccine" (California Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,874, issued on June 16, was assigned to ImmunityBio Inc. (San Diego) and NantCell Inc. (Culver City, Calif.).

"Nant cancer vaccine" was invented by Patrick Soon-Shiong (Culver City, Calif.), Kayvan Niazi (Culver City, Calif.), Shahrooz Rabizadeh (Agoura Hills, Calif.), Hans G. Klingemann (Culver City, Calif.), Laurent H. Boissel (Culver City, Calif.) and Barry J. Simon (Culver City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Cancer is treated using coordinated treatment regimens that uses various compounds and compositions that drive a tumor from the escape phase of cancer immunoediting to the elimination and equilibrium phase of cancer i...